Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 8,593 shares at $15.22 ($131K) on 2022-09-26, disclosed to the SEC on 2022-09-28.
Scheduled sale ($131k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.22 | 2,768 | $42K | 32.1% |
| 2 | $16.33 | 300 | $5K | 3.7% |
| 3 | $15.31 | 2,403 | $37K | 28.0% |
| 4 | $15.25 | 3,122 | $48K | 36.2% |
| Total | $15.29 avg | 8,593 | $131K | 100% |
| Filing → |
| TRDA | SELL | 2023-08-04 | $771K | — | Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |